IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

SIMONE, CHIARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.093
EU - Europa 3.460
AS - Asia 3.036
SA - Sud America 260
AF - Africa 112
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 4
Totale 10.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.896
GB - Regno Unito 1.220
CN - Cina 933
SG - Singapore 925
IT - Italia 524
DE - Germania 388
SE - Svezia 331
BD - Bangladesh 314
HK - Hong Kong 253
RU - Federazione Russa 244
BR - Brasile 191
VN - Vietnam 173
FR - Francia 156
FI - Finlandia 154
CA - Canada 151
KR - Corea 113
NL - Olanda 98
IN - India 92
IE - Irlanda 81
CI - Costa d'Avorio 58
UA - Ucraina 58
TR - Turchia 53
DK - Danimarca 43
JP - Giappone 41
EU - Europa 40
BE - Belgio 35
PL - Polonia 35
ID - Indonesia 34
NG - Nigeria 28
AR - Argentina 24
AU - Australia 22
MX - Messico 22
CO - Colombia 21
ES - Italia 19
TW - Taiwan 15
GR - Grecia 14
ZA - Sudafrica 12
AT - Austria 11
CZ - Repubblica Ceca 10
IQ - Iraq 9
SA - Arabia Saudita 9
IL - Israele 8
AZ - Azerbaigian 7
CL - Cile 7
HN - Honduras 7
RO - Romania 7
TH - Thailandia 7
VE - Venezuela 7
BG - Bulgaria 6
LT - Lituania 5
MY - Malesia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
EE - Estonia 4
JO - Giordania 4
KZ - Kazakistan 4
UZ - Uzbekistan 4
BO - Bolivia 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
PK - Pakistan 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
CM - Camerun 2
EC - Ecuador 2
GA - Gabon 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
EG - Egitto 1
GD - Grenada 1
GE - Georgia 1
GL - Groenlandia 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
NI - Nicaragua 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SX - ???statistics.table.value.countryCode.SX??? 1
TJ - Tagikistan 1
Totale 11.029
Salva come PNG Salva come JPEG
Città #
Southend 1.087
Singapore 572
Ashburn 481
Chandler 331
Dallas 292
Hong Kong 230
San Jose 214
Houston 182
Beijing 180
Fairfield 164
Wilmington 157
Milan 148
Seattle 146
Ann Arbor 117
Princeton 113
Toronto 105
Woodbridge 102
Council Bluffs 100
Helsinki 86
Los Angeles 81
Dublin 78
New York 75
Boardman 72
Santa Clara 69
Abidjan 58
Ho Chi Minh City 51
Guangzhou 48
Phoenix 48
Nanjing 46
Buffalo 45
Lauterbourg 45
Shanghai 40
Hanoi 39
Cambridge 38
Frankfurt am Main 38
Grafing 38
Mountain View 37
Bengaluru 36
Redmond 36
Munich 35
Warsaw 34
Moscow 32
Des Moines 31
Dearborn 30
Lekki 28
Jinan 27
Brussels 26
Shenyang 26
Hangzhou 24
Jakarta 23
Rome 23
Somerville 23
The Dalles 23
Cangzhou 21
Redwood City 21
Tokyo 21
Bitonto 19
Columbus 19
Sakarya 19
Norwalk 18
Andover 17
Ottawa 17
Seongnam 17
Changsha 16
São Paulo 16
Turku 16
Bogotá 15
Fuzhou 15
Medford 15
Nanchang 15
Kiez 14
Eitensheim 13
London 13
Seoul 13
Washington 13
Zhengzhou 13
Jacksonville 12
Taipei 12
Amsterdam 11
Atlanta 11
Hebei 11
Ningbo 11
Quanzhou 11
Serra 11
Düsseldorf 10
Florence 10
Hamburg 10
Hanover 10
Roxbury 10
San Diego 10
Shenzhen 10
Tianjin 10
Brno 9
Montreal 9
Mumbai 9
Philadelphia 9
Silver Spring 9
Athens 8
Brasília 8
Chicago 8
Totale 6.825
Salva come PNG Salva come JPEG
Nome #
GENERAZIONE E CORREZIONE DI CELLULE STAMINALIPLURIPOTENTI INDOTTE NON VIRALI DA PAZIENTE SMA COMEMODELLO DI MALATTIA E SORGENTE PER LA TERAPIA CELLULARE 435
Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model 424
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 394
Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches 384
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 369
Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications? 313
IPSC-derived neural stem cells act via kinase inhibition to exert neuroprotective effects in spinal muscular atrophy with respiratory distress type 1 294
Direct reprogramming of adult somatic cells into other lineages: past evidence and future perspectives 289
Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma 285
Morpholino-mediated SOD1 reduction ameliorates an amyotrophic lateral sclerosis disease phenotype 283
Motor neuron derivation from human embryonic and induced pluripotent stem cells: experimental approaches and clinical perspectives 276
Differential neuronal vulnerability identifies IGF-2 as a protective factor in ALS 264
Embryonic stem cell–derived neural stem cells improve spinal muscular atrophy phenotype in mice 259
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 252
Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS 247
Motor neurons from human spinal muscular atrophy–induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 246
Antisense Oligonucleotide Therapy for the Treatment of C9ORF72 ALS/FTD Diseases 236
Therapeutic Development in Amyotrophic Lateral Sclerosis 236
Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model 225
ALS genetic modifiers that increase survival of SOD1 mice and are suitable for therapeutic development 222
Direct reprogramming of human astrocytes into neural stem cells and neurons 219
Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms 210
Motoneurons from human spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences as a model and cell source for transplantation 205
Pluripotent engineered stem cell-derived neural stem cells improve spinal muscular atrophy phenotype in mice 196
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 193
Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy 192
Development of a therapeutic approach for Spinal Muscular Atrophy with Respiratory Distress (SMARD1) using human induced pluripotent stem cell-derived neural stem cells and motor neurons 191
Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis 188
Molecular, genetic and stem cell-mediated therapeutic strategies for spinal muscular atrophy (SMA) 184
MFN2-related neuropathies: clinical features, molecular pathogenesis and therapeutic perspectives 181
Genetic correction of spinal muscular atrophy-induced pluripotent stem cells and motoneurons as a disease model and cell source for transplantation 180
Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis 178
Directing human astrocytes into neural stem cells and neurons as possible tool for repair in CNS diseases 177
Molecular therapeutic strategies for spinal muscular atrophies : Current and future clinical trials 176
Pluripotent stem cell-based models of spinal muscular atrophy 171
A model for motor neuron degeneration and treatment of Spinal Muscular Atrophy using human induced pluripotent stem cells 170
Gene Corrected Spinal Muscular Atrophy-Induced Pluripotent Stem Cells and Motoneuron as a Model and Cell Source for Transplantation (IN8-2.002) 169
Neural stem cells derived from genetically engineered lineage-selectable Es cells improves the phenotype of a mouse model of spinal muscular atrophy 168
Neuroprotection in spinal muscular atrophy (SMA) using neural stem cells as a therapeuthic approach 168
Effect of combined systemic and local morpholino treatment on the spinal muscular atrophy δ7 mouse model phenotype 168
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of amyotrophic lateral sclerosis 167
Beta lactam antibiotic ameliorates spinal muscular atrophy phenotype in a mouse model by multiple mechanisms 166
Targeted gene correction of spinal muscular atrophy induced pluripotent stem cells and motoneurons as cell source for therapy 166
Beta-lactam antibiotic offer neuroprotection in a spinal muscular atrophy mouse model by multiple mechanisms 163
Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells 158
Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation 158
The wide spectrum of clinical phenotypes of spinal muscular atrophy with respiratory distress type 1: a systematic review 153
Transplantation of neural stem cells derived from genetically engineered, lineage-selectable ES cells improves spinal muscular atrophy 147
Generation of motoneurons from spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences : in vitro and In vivo analysis 146
Systemic transplantation of c-kit+ cells can ameliorate the phenotype of a mouse model of Amyotrophic Lateral Sclerosis 141
In vitro and in vivo analysis of motoneurons obtained from human-spinal muscular atrophy-induced pluripotent stem cells free of vector and transgenic sequences 137
Systemic transplantation of c-kit+ cells exerts a therapeutic effect in a model of Amyotrophic Lateral Sclerosis 125
Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer 41
null 4
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
null 3
Totale 11.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.066
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.066
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202169 0 0 0 0 0 0 0 0 0 0 0 69
2021/2022766 45 64 24 47 40 54 39 25 127 86 62 153
2022/2023934 124 124 85 107 110 153 26 52 108 12 25 8
2023/2024633 21 38 36 68 149 68 21 33 25 33 55 86
2024/20251.546 66 131 72 188 100 62 31 126 94 150 175 351
2025/20263.487 343 140 538 271 285 207 305 120 312 207 444 315
Totale 11.516